Advanced imaging uncovers that glioblastoma affects the skull and immune system, not just the brain.
Key Details
- 1Montefiore Einstein researchers found glioblastoma erodes skull bones and alters skull marrow immune makeup.
- 2CT imaging of patients showed similar skull erosions as seen in mouse models with glioblastoma.
- 3Single-cell RNA sequencing revealed a shift toward pro-inflammatory immune cells in the skull marrow.
- 4FDA-approved osteoporosis drugs halted skull erosion but made tumors more aggressive and impaired immunotherapy effects.
- 5Findings suggest glioblastoma should be seen as a systemic, not just local, disease.
Why It Matters
These findings highlight the need for radiologists to consider extracranial effects when imaging glioblastoma and suggest that traditional local-treatment approaches may overlook critical systemic interactions. Understanding these effects can influence both diagnostic imaging strategies and future treatment planning.
Source
EurekAlert
Related News
•EurekAlert
New VIS-Fb Nanobody Probes Transform High-Precision Cellular Imaging
Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.